Black Rock Inc. Celldex Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,690,761 shares of CLDX stock, worth $112 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,690,761
Previous 4,511,924
3.96%
Holding current value
$112 Million
Previous $189 Million
8.32%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CLDX
# of Institutions
198Shares Held
68.2MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$145 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$125 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$94.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$90.9 Million0.01% of portfolio
-
Commodore Capital LP New York, NY3.45MShares$82.1 Million6.54% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.11B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...